Animal models of substance abuse and addiction: Implications for science, animal welfare, and society

Comparative Medicine

Volumn 60, Issue 3, 2010, Pages 177-188

  Lynch, Wendy J ^a   Nicholson, Katherine L ^c   Dance, Mario E ^c   Morgan, Richard W ^a   Foley, Patricia L ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; COCAINE; CODEINE; DIAMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; MORPHINE; NALOXONE; NICOTINE; OPIATE; SACCHARIN;

ADDICTION; ALCOHOL ABUSE; ALCOHOLISM; ANIMAL DISEASE; ANIMAL WELFARE; DRUG SCREENING; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SCIENCE; SOCIAL PROBLEM; SOCIETY; SUBSTANCE ABUSE; VETERINARY ABORTION; ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; BEHAVIOR, ADDICTIVE; ECONOMICS; ETHICS; EXPERIMENTAL ANIMAL; HUMAN; INSTRUMENTAL CONDITIONING; NATIONAL HEALTH ORGANIZATION; ORGANIZATION; STANDARDS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ANIMAL WELFARE; ANIMALS; ANIMALS, LABORATORY; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; HUMANS; MODELS, ANIMAL; NATIONAL INSTITUTES OF HEALTH (U.S.); SOCIETIES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 77954183162     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Ahmed SH, Koob GF. 1998. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298-300.
2. Ahmed SH, Walker JR, Koob GF. 2000. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22:413-421.
3. Ator NA, Griffiths RR. 1987. Self-administration of barbiturates and benzodiazepines: a review. Pharmacol Biochem Behav 27:391-398.
4. Balster RL. 1991. Drug abuse potential evaluation in animals. Br J Addict 86:1549-1558.
5. Balster RL, Bigelow GE. 2003. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend 70:S13-S40. (Pubitemid 36577513)
6. Banks ML, Gould RW, Czory PW, Nader MA. 2008. Relationship between response rates and measures of reinforcing strength using a choice procedure in monkeys. Behav Pharmacol 19:365-369.
7. Bardo MT, Rowlert JK, Harris MJ. 1995. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19:39-51.
8. Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS. 2004. Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys. Exp Clin Psychopharmacol 12:163-172.
9. Ben-Shahar O, Moscarello JM, Ettenberg A. 2006. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter. Brain Res 1095:148-153.
10. Benjamin E, Oropello JM, Abalos AM, Hannon EM, Wang JK, Fischer E, Iberti TJ. 1994. Effects of acid-base correction on hemodynamics, oxygen dynamics, and resuscitability in severe canine hemorrhagic shock. Crit Care Med 22:1616-1623. (Pubitemid 24320886)
11. Bozarth M. 1990. Drug addiction as a psychobiological process, p 112-134. In: Warburton DM, editor. Addiction controversies. London (UK): Harwood Academic Publishers.
12. Brady KT, Woolverton WL, Balster RL. 1982. Discriminative stimulus and reinforcing properties of etoxadrol and dexoxadrol in monkeys. J Pharmacol Exp Ther 220:56-62. (Pubitemid 12219288)
13. Briand LA, Flagel SB, Garcia-Fuster MJ, Watson SJ, Akil H, Sarter M, Robinson TE. 2008. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 33:2969-2980.
14. Brunton LL, Lazo JS, Parker KL, editors. 2006. Goodman and Gilman's the pharmacological basis of therapeutics, 11th ed. New York (NY): McGraw-Hill.
15. Campbell UC, Carroll ME. 2000. Acquisition of drug self-administration: environmental and pharmacological interventions. Exp Clin Psychopharmacol 8:312-325.
16. Carroll ME, Lac ST. 1993. Autoshaping IV cocaine self-administration in rats: effects of nondrug alternative reinforcers on acquisition. Psychopharmacology (Berl) 110:5-12.
17. Carroll ME, Lac ST. 1998. Dietary additives and the acquisition of cocaine self-administration in rats. Psychopharmacology (Berl) 137:81-89. (Pubitemid 28225007)
18. Carroll ME, Lac ST, Nygaard SL. 1989. A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology (Berl) 97:23-29.
19. Carroll ME, Mattox AJ. 1997. Drug reinforcement in animals, p 3-38. In: Johnson BA, Roache JD, editors. Drug addiction and its treatment: nexus of neuroscience and behavior. New York (NY): Lippencott-Raven Press.
20. Carroll ME, Meisch RA. 1979. Effects of food deprivation on etonitazene consumption in rats. Pharmacol Biochem Behav 10:155-159. (Pubitemid 9168078)
21. Cartwright WS. 1999. Costs of drug abuse to society. J Ment Health Policy Econ 2:133-134.
22. Centers for Disease Control and Prevention, National Center for Health Statistics. 2006. Health, United States, 2006, with chartbook on trends in the health of Americans with special feature on pain. Washington (DC): US Department of Health and Human Services.
23. Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR. 1984. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl) 82:6-13.
24. Davis BA, Clinton SM, Akil H, Becker JB. 2008. The effects of novelty-seeking phenotypes and sex differences on acquisition of cocaine self-administration in selectively bred high-responder and low-responder rats. Pharmacol Biochem Behav 90:331-338.
25. Fattore L, Piras G, Corda MG, Giorgi O. 2009. The Roman high- and low-avoidance rat lines differ in the acquisition, maintenance, extinction, and reinstatement of intravenous cocaine self-administration. Neuropsychopharmacology 34:1091-1101.
26. Ferrario CR, Gorny G, Crombag HS, Li Y, Kolb B, Robinson TE. 2005. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 58:751-759. (Pubitemid 41547244)
27. Fitch TE, Roberts DC. 1993. The effects of dose and access restrictions on the periodidty of cocaine self-administration in the rat. Drug Alcohol Depend 33:119-128.
28. Foley PL, Barthel CH, Brausa HR. 2002. Effect of covalently bound heparin coating on patency and biocompatibility of long-term indwelling catheters in the rat jugular vein. Comp Med 52:243-248.
29. Fox JG. 2007. The mouse in biomedical research. Amsterdam (the Netherlands): Academic Press.
30. French ED, Lopez M, Peper S, Kamenka JM, Roberts DC. 1995. A comparison of the reinforcing efficacy of PCP, the PCP derivatives TCP and BTCP, and cocaine using a progressive ratio schedule in the rat. Behav Pharmacol 6:223-228.
31. George O, Mandyam CD, Wee S, Koob GF. 2008. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology 33:2474-2482.
32. Glick SD, Raucci J, Wang S, Keller RWJ, Carlson JN. 1994. Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res 653:148-154. (Pubitemid 24252832)
33. Gosnell BA, Krahn DD, Yracheta JM, Harasha BJ. 1998. The relationship between intravenous cocaine self-administration and avidity for saccharin. Pharmacol Biochem Behav 60:229-236.
34. Greenberg JA, Boozer CN. 2000. Metabolic mass, metabolic rate, caloric restriction, and aging in male Fischer 344 rats. Mech Ageing Dev 113:37-48.
35. Griffiths RR, Balster RL. 1979. Opioids: similarity between evaluations of subjective effects and animal self-administration results. Clin Pharmacol Ther 25:611-617.
36. Griffiths RR, Bigelow GE, Henningfield JE. 1980. Similarities in animal and human drug-taking behavior, p 1-90. In: Mello NK, editor. Advances in substance abuse. Stamford (CT): JAI Press.
37. Griffiths RR, Brady JV, Bradford LD. 1979. Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens., p. 163-208. In: Thompson T, Dews P, editors. Advances in behavioral pharmacology, vol 2. New York (NY): Academic Press.
38. Higgins GA, Sellers EM. 1994. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav 48:1-8.
39. Holtzman SG. 1990. Discriminative stimulus effects of drugs: relationship to potential for abuse, p 193-210. In: Adler MW, Cowan A, editors. Testing and evaluation of drugs of abuse. Modern methods in pharmacology, vol 6. New York (NY): Wiley-Liss.
40. Homberg JR, van der Akker M, Raaso HS, Wardeh G, Binnekade R, Schoffelmeer AN, de Vries TJ. 2002. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur J Neurosci 15:1542-1550. (Pubitemid 35477985)
41. Johanson CE. 1990. The evaluation of the abuse liability of drugs. Drug Saf 5 Suppl 1:46-57.
42. Johanson CE, Balster RL. 1978. A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 30:43-54.
43. Jolivette LJ, Ward KW. 2005. Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: molecular properties associated with extrapolative success or failure. J Pharm Sci 94:1467-1483.
44. Katz JL, Higgins ST. 2003. The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168:21-30.
45. Keane B, Leonard BE. 1989. Rodent models of alcoholism: a review. Alcohol Alcohol 24:299-309.
46. Kippin TE, Fuchs RA, See RH. 2006. Contributions of prolonged contingent and noncontingent cocaine exposure to enhanced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 187:60-67.
47. Koob GF. 2003. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol 13:442-452. (Pubitemid 37433964)
48. Le A, Shaham Y. 2002. Neurobiology of relapse to alcohol in rats. Pharmacol Ther 94:137-156.
49. Li TK. 2000. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. J Stud Alcohol 61:5-12.
50. Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR. 2001. The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend 63:107-116. (Pubitemid 32488924)
51. Little HJ. 1991. The benzodiazepines: anxiolytic and withdrawal effects. Neuropeptides 19 Suppl:11-14.
52. Lynch WJ. 2006. Sex differences in vulnerability to drug self-administration. Exp Clin Psychopharmacol 14:34-41.
53. Lynch WJ, Carroll ME. 1999. Sex differences in the acquisition of intravenously self-administered cocaine and heroine in rats. Psychopharmacology (Berl) 144:77-82.
54. Lynch WJ, Taylor JR. 2004. Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology 29:943-951.
55. Magalon K, Cantarella C, Monti G, Cayre M, Durbec P. 2007. Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models. Eur J Neurosci 25:761-771.
56. Maldonado C, Rodriquez-Arias M, Castillo A, Aguilar MA, Minarro J. 2007. Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference. Prog Neuropsychopharmacol Biol Psychiatry 31:932-939.
57. Malin DH, Goyarzu P. 2009. Rodent models of nicotine withdrawal syndrome. Handb Exp Pharmacol 192:401-434.
58. Mantsch JR, Ho A, Schlussman SD, Kreek MJ. 2001. Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) 157:31-39.
59. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ. 2004. Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement, and brain mRNA levels in rats. Psychopharmacology (Berl) 175:26-36. (Pubitemid 39215527)
60. Markou A, Weiss F, Gold LH, Barak Caine S, Schulteis G, Koob GF. 1993. Animal models of drug craving. Psychopharmacology (Berl) 112:163-182.
61. Mathieu-Kia AM, Fan LQ, Kreek MJ, Simon EJ, Hiller JM. 2001. Mu-, delta-, and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Brain Res 893:121-134.
62. McCallum SE, Glick SD. 2009. Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference. Neurosci Lett 458:57-59.
63. Meisch RA. 1987. Factors controlling drug reinforced behavior. Pharmacol Biochem Behav 27:367-371.
64. Mello NK, Negus SS. 1996. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
65. Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, O'Donnell D. 2003. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465:349-360. (Pubitemid 37174200)
66. Morgan D, Brebner K, Lynch WJ, Roberts DC. 2002. Increases in the reinforcing efficacy of cocaine after particular histories of reinforcement. Behav Pharmacol 13:389-396.
67. Mucha RF, Van der Kooy D, O'Shaughnessy M, Bucenieks P. 1982. Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91-105. (Pubitemid 12082367)
68. Myers KM, Carlezon WA Jr. 2010. D-Cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats. Biol Psychiatry 67:85-87.
69. National Center on Addiction and Substance Abuse. 2009. Shoveling up II: the impact of substance abuse on federal, state, and local budgets. New York (NY): Columbia University.
70. Nicholson KL, Mansbach RS, Menniti FS, Balster RL. 2007. The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP101 606 in rats and rhesus monkeys. Behav Pharmacol 18:731-743.
71. National Institute on Drug Abuse. [Internet]. 2007. Drugs, brains, and behavior: the science of addiction. [Cited 05 Feb 2010.] Available at http://www.drugabuse.gov/scienceofaddiction/sciofaddiction.pdf.
72. Niyuhire F, Varvel SA, Martin BR, Lichtman AH. 2007. Exposure to marijuana smoke impairs memory retrieval in mice. J Pharmacol Exp Ther 322:1067-1075. (Pubitemid 47295775)
73. Office of National Drug Control Policy. 2001. The economic costs of drug abuse in the United States, 1992-1998. Washington (DC): Executive Office of the President Office of National Drug Control Policy.
74. Percy DH, Barthold SW. 2001. Pathology of laboratory rodents and rabbits. Ames (IA): Iowa State University Press.
75. Perry JL, Anderson MM, Nelson SE, Carroll ME. 2007. Acquisition of intravenous cocaine self-administration in adolescent and adult male rats selectively bred for high and low saccharin intake. Physiol Behav 91:126-133.
76. Perry JL, Morgan AD, Anker JJ, Dess NK, Carroll ME. 2006. Escalation of TV cocaine self-administration and reinstatement of cocaine-seeking behavior in rats bred for high and low saccharin intake. Psychopharmacology (Berl) 186:235-245.
77. Perry JL, Nelson SE, Carroll ME. 2008. Impulsive choice as a predictor of acquisition of intravenous cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 16:165-177.
78. Piazza PV, Maccari S, Deminier JM, Le Moal M, Mormede P, Simon H. 1991. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 88:2088-2092.
79. Pinel JP. 1980. Alcohol withdrawal seizures: implications of kindling. Pharmacol Biochem Behav 13 Suppl 1:225-231.
80. Preston KL, Bigelow GE. 1991. Subjective and discriminative effects of drugs. Behav Pharmacol 2:293-313.
81. Pugh TD, Klopp RG, Weindruch R. 1999. Controlling caloric consumption: protocols for rodents and rhesus monkeys. Neurobiol Aging 20:157-165. (Pubitemid 29488726)
82. Roberts DC, Brebner K, Vincler M, Lynch WJ. 2002. Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure. Drug Alcohol Depend 67:291-299.
83. Roberts DC, Morgan D, Liu Y. 2007. How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 31:1614-1624.
84. Rocha BA, Ward AS, Egilmez Y, Lytle DA, Emmett-Oglesby MW. 1996. Tolerance to the discriminative stimulus and reinforcing effects of ketamine. Behav Pharmacol 7:160-168.
85. Rogers JL, DeSantis S, See RE. 2008. Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berl) 199:615-624.
86. 4Cl on intra- and extracellular acid-base equilibrium studies in the rat. J Med 15:135-148. (Pubitemid 14010983)
87. Schechter MD, Schechter JB, Calcagnetti DJ. 1992. Direct microinjection of cathinone into the rat brain produces discriminative stimuli. Pharmacol Biochem Behav 42:619-623.
88. Schuster CR, Johanson CE. 1988. Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacol Ser 4:161-175.
89. Scorza FA, Arida RM, Cysneiros RM, Priel MR, de Albuquerque M, Cavalheiro EA. 2003. The effects of alcohol intake and withdrawal on the seizures frequency and hippocampal morphology in rats with epilepsy. Neurosci Res 47:323-328.
90. Senay EC. 1989. Addictive behaviors and benzodiazepines. 1. Abuse liability and physical dependence. Adv Alcohol Subst Abuse 8:107-124.
91. Shahbazi M, Moffet AM, Williams BF, Frantz KJ. 2008. Age- and sex-dependent amphetamine self-administration in rats. Psychopharmacology (Berl) 196:71-81.
92. Shalev U, Grimm JW, Shaham Y. 2002. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1-42. (Pubitemid 34208828)
93. Shoaib M, Schindler CW, Goldberg SR. 1997. Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129:35-43. (Pubitemid 27037448)
94. Sim-Selley LJ, Childers SR. 2002. Neuroanatomical localization of receptor-activated G proteins in brain. Methods Enzymol 344:42-58.
95. Sim-Selley LJ, Daunais JB, Porrino LJ, Childers SR. 1999. Mu and kappal opioid-stimulated [35S]guanylyl-5′-0-(gamma-thio)-triphosphate binding in cynomolgus monkey brain. Neuroscience 94:651-662.
96. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. 2003. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290:2443-2454. (Pubitemid 37430544)
97. Substance Abuse and Mental Health Services Administration. 2008. Results from the 2007 national survey on drug use and health: national findings. Rockville (MD): Office of Applied Studies.
98. Sutton MA, Karanian DA, Self DW. 2000. Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats. Neuropsychopharmacology 22:626-641. (Pubitemid 30219406)
99. Tang W, Wesley M, Freeman WM, Liang B, Hemby SE. 2004. Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. J Neurochem 89:1021-1033. (Pubitemid 38684747)
100. Thomas MJ, Kalivas PW, Shaham Y. 2008. Neuroplastidty in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154:327-342. (Pubitemid 351670603)
101. Tornatzky W, Miczek KA. 2000. Cocaine self-administration 'binges': transition from behavioral and autonomic regulation toward homeostatic dysregulation in rats. Psychopharmacology (Berl) 148:289-298.
102. Tzschentke TM, Magalas Z, De Vry J. 2006. Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat. Addict Biol 11:64-71. (Pubitemid 46696743)
103. Valentino RJ, Herling S, Woods JH, Medzihradsky F, Merz H. 1981. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists. J Pharmacol Exp Ther 217:652-659.
104. Vargas-Irwin C, van den Oord EJ, Beardsley PM, Robles JR. 2006. A method for analyzing strain differences in acquisition of IV cocaine self-administration in mice. Behav Genet 36:525-535.
105. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N. 1997. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386:830-833.
106. Ward KW, Smith BR. 2004. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. Drug Metab Dispos 32:603-611.
107. Ward KW, Smith BR. 2004. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. Drug Metab Dispos 32:612-619.
108. Ward SJ, Lack C, Morgan D, Roberts DC. 2006. Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology (Berl) 185:150-159.
109. Wersinger SR, Martin LB. 2009. Optimization of laboratory conditions for the study of social behavior. ILAR J 50:64-80.
110. Winger G, Stitzer ML, Woods JH. 1975. Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. J Pharmacol Exp Ther 195:505-514.
111. Wise RA. 1998. Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
112. World Health Organization. [Internet]. 2009. Management of substance abuse. [Cited 03 Feb 2010]. Available at http://www.who.int/substance-abuse/ facts/en/index.html.
113. Young AM, Woods JH. 1981. Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther 218:720-727.
114. Zakharova E, Wade D, Izenwasser S. 2009. Sensitivity to cocaine conditioned reward depends on sex and age. Pharmacol Biochem Behav 92:131-134.